ADIPOQ and Insulin resistance: Apart from the pro-metabolic role play assigned to AdipoR agonism in improving systemic insulin resistance and oxidative stress, we would like to underscore its target-organ specific effect via activating AdipoR1 and AdipoR2 expressions in the myocardium, independent of the systemic effects of adiponectin.